See more : Aridis Pharmaceuticals, Inc. (ARDS) Income Statement Analysis – Financial Results
Complete financial analysis of Clinigence Holdings, Inc. (CLNH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clinigence Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Lithia Motors, Inc. (LAD) Income Statement Analysis – Financial Results
- Eagle Cold Storage Enterprise Co., Ltd. (8905.TWO) Income Statement Analysis – Financial Results
- iShares 1-5 Year Laddered Corporate Bond Index ETF (CBO) Income Statement Analysis – Financial Results
- Jiangsu Maixinlin Aviation Science and Technology Corp. (688685.SS) Income Statement Analysis – Financial Results
- XNET Corporation (4762.T) Income Statement Analysis – Financial Results
Clinigence Holdings, Inc. (CLNH)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://ahahealthcare.net
About Clinigence Holdings, Inc.
Clinigence Holdings, Inc. provides health care services. It offers medicare management, performance metrics, cost improvement and performance improvement plans, and health management services. The company was incorporated in 2014 and is based in Fort Lauderdale, Florida.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.79K | 1.59K | 1.37M | 60.22K | 23.17K | 0.00 | 474.68K | 1.07M | 1.46M | 1.59M | 1.78M | 874.77K | 173.01K | 0.00 |
| Cost of Revenue | 14.65K | 909.78 | 830.44K | 31.15K | 30.48K | 0.00 | 8.05K | 465.34K | 496.01K | 783.51K | 764.75K | 391.59K | 47.46K | 0.00 |
| Gross Profit | 4.15K | 676.17 | 535.98K | 29.08K | -7.32K | 0.00 | 466.63K | 603.28K | 965.18K | 810.38K | 1.02M | 483.19K | 125.55K | 0.00 |
| Gross Profit Ratio | 22.06% | 42.64% | 39.22% | 48.28% | -31.58% | 0.00% | 98.30% | 56.45% | 66.05% | 50.84% | 57.13% | 55.24% | 72.57% | 0.00% |
| Research & Development | 285.88 | 557.26 | 768.10K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 12.18K | 3.25K | 3.67M | 1.16M | 1.81M | 448.60K | 965.61K | 1.38M | 1.69M | 2.38M | 0.00 | 1.83M | 861.51K | 196.59K |
| Selling & Marketing | 24.45 | 166.76 | 577.74K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 12.20K | 3.42K | 4.24M | 1.16M | 1.81M | 448.60K | 965.61K | 1.38M | 1.69M | 2.38M | 0.00 | 1.83M | 861.51K | 196.59K |
| Other Expenses | 677.17 | 1.89K | 163.75K | 695.87K | 533.89K | -897.19K | 0.00 | 0.00 | 0.00 | 0.00 | 1.86M | 0.00 | 0.00 | -393.18K |
| Operating Expenses | 13.16K | 5.86K | 5.18M | 1.86M | 2.35M | -448.60K | 965.61K | 1.38M | 1.69M | 2.38M | 1.86M | 1.83M | 861.51K | -196.59K |
| Cost & Expenses | 27.81K | 6.77K | 8.26M | 1.89M | 5.72M | 448.60K | 973.66K | 1.85M | 2.19M | 3.17M | 2.63M | 2.22M | 908.97K | 196.59K |
| Interest Income | 0.92 | 1.03K | 3.63K | 0.00 | 0.00 | 114.00 | 4.00 | 152.08K | 0.00 | 13.24K | 29.14K | 8.27K | 3.91K | 2.55K |
| Interest Expense | 784.01 | 335.45 | 92.16K | 642.07K | 367.35K | 2.58K | 44.60K | 10.33K | 54.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.65 | 14.51K | 171.82K | 697.60K | 535.02K | 473.00 | 4.92K | 4.77K | 6.69K | 8.75K | 5.92K | 1.50K | 596.00 | 373.00 |
| EBITDA | -11.90K | 9.20K | -6.85M | -1.08M | 1.88M | -7.43M | 133.32K | -669.24K | 311.69K | -1.52M | -645.94K | -339.14K | 192.28K | 359.70K |
| EBITDA Ratio | -63.30% | 580.05% | -501.50% | -1,797.59% | 8,099.97% | 0.00% | 28.09% | -62.63% | 21.33% | -95.44% | -36.21% | -38.77% | 111.14% | 0.00% |
| Operating Income | -11.90K | -5.19M | -6.90M | -1.83M | -5.69M | -448.60K | -498.98K | -780.37K | -727.38K | -1.57M | -844.58K | -1.35M | -735.96K | -196.59K |
| Operating Income Ratio | -63.33% | -327,103.34% | -504.81% | -3,039.59% | -24,574.46% | 0.00% | -105.12% | -73.03% | -49.78% | -98.70% | -47.34% | -153.89% | -425.38% | 0.00% |
| Total Other Income/Expenses | -784.01 | 5.18M | -218.67K | -591.68K | 6.67M | -2.47K | -44.59K | 78.49K | 660.25K | 43.24K | 29.14K | 8.27K | 3.91K | 2.55K |
| Income Before Tax | -12.68K | -5.65K | -7.12M | -2.42M | 974.06K | -451.06K | -543.58K | -701.87K | -67.14K | -1.53M | -815.44K | -1.34M | -732.05K | -194.04K |
| Income Before Tax Ratio | -67.50% | -356.26% | -520.82% | -4,022.06% | 4,204.71% | 0.00% | -114.51% | -65.68% | -4.59% | -95.99% | -45.71% | -152.95% | -423.12% | 0.00% |
| Income Tax Expense | 984.81 | 5.18M | -126.51K | 392.00K | 392.00K | 114.00 | 4.00 | 88.83K | 714.75K | 93.94K | -268.46K | -498.78K | -254.07K | -44.07K |
| Net Income | -13.67K | -5.65K | -7.12M | -2.81M | 582.06K | -7.43M | 83.81K | -684.34K | 250.49K | -1.62M | -383.39K | 158.14K | 445.76K | 403.39K |
| Net Income Ratio | -72.74% | -356.26% | -520.82% | -4,672.96% | 2,512.57% | 0.00% | 17.66% | -64.04% | 17.14% | -101.88% | -21.49% | 18.08% | 257.65% | 0.00% |
| EPS | 0.00 | 0.00 | -1.96 | -9.79 | 3.48 | -93.63 | 1.44 | -13.19 | 5.00 | -33.89 | -8.00 | 3.30 | 9.69 | 9.00 |
| EPS Diluted | 0.00 | 0.00 | -1.96 | -9.79 | 3.48 | -93.63 | 1.35 | -12.50 | 4.82 | -33.89 | -8.00 | 3.30 | 9.69 | 9.00 |
| Weighted Avg Shares Out | 4.94M | 4.94M | 3.63M | 287.37K | 167.34K | 79.38K | 58.34K | 51.90K | 50.09K | 47.91K | 47.91K | 47.91K | 46.02K | 44.80K |
| Weighted Avg Shares Out (Dil) | 4.94M | 4.94M | 3.63M | 287.37K | 167.34K | 79.38K | 61.92K | 54.75K | 51.98K | 47.91K | 47.91K | 47.91K | 46.02K | 44.80K |
7 OTC Stocks That Made It Big in 2021 for Multiple Reasons
OTC stocks are often difficult to gauge. These seven that made it big in 2021 are no different but remain interesting stories.
Source: https://incomestatements.info
Category: Stock Reports